Tempus AI Inc. ($TEM) shares have experienced a notable rally following strong second-quarter earnings and increased bullish option activity. The stock has shown a rapid upward movement with gains of around 10% from recent buys, supported by a bullish descending channel technical pattern. Analyst BTIG has raised its price target for Tempus AI to $85, reflecting optimism about the company's strategic expansions. A key development contributing to the positive outlook is a $200 million data partnership deal with AstraZeneca. Tempus AI's current market capitalization stands at $12.7 billion. The stock's performance has been compared to that of Palantir Technologies Inc. ($PLTR), with both showing correlated upward trends recently.